As of 2024-12-13, the Intrinsic Value of Evolent Health Inc (EVH) is
14.62 USD. This EVH valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 11.40 USD, the upside of Evolent Health Inc is
28.30%.
The range of the Intrinsic Value is 7.11 - 46.07 USD
14.62 USD
Intrinsic Value
EVH Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
7.11 - 46.07 |
14.62 |
28.3% |
| DCF (Growth 10y) |
20.94 - 102.92 |
36.82 |
223.0% |
| DCF (EBITDA 5y) |
4.99 - 18.85 |
11.27 |
-1.1% |
| DCF (EBITDA 10y) |
13.79 - 37.51 |
23.95 |
110.1% |
| Fair Value |
-3.10 - -3.10 |
-3.10 |
-127.18% |
| P/E |
(23.82) - (32.62) |
(31.51) |
-376.4% |
| EV/EBITDA |
1.51 - 11.98 |
7.88 |
-30.9% |
| EPV |
6.19 - 11.18 |
8.69 |
-23.8% |
| DDM - Stable |
(4.98) - (25.97) |
(15.48) |
-235.8% |
| DDM - Multi |
5.80 - 24.71 |
9.53 |
-16.4% |
EVH Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,328.78 |
| Beta |
-0.60 |
| Outstanding shares (mil) |
116.56 |
| Enterprise Value (mil) |
1,831.87 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.43% |
| Cost of Debt |
6.36% |
| WACC |
8.18% |